資料搜尋諮詢服務
找不到您所需要的資料嗎?
我們能協助您找到最符合您研究需求的資訊
請撥打 +886-2-2799-3110
或透過電子郵件與我們聯絡 mi@hintoninfo.com
IHS_EWBIEEE xploreSTRATEGY ANALYTICSIHS_EWB_GF

Electrophoresis Market by Product , Application & End User - Global Forecast to 2020

  • LinkedIn
  • facebook
  • Twitter
出 版 商:MarketsandMarkets
出版日期:2015/05/22
頁  數:233頁
文件格式:PDF
價  格:
USD 4,650 (Single-User License)
USD 5,650 (Multi-User License)
USD 9,000 (Global-User License)
線上訂購或諮詢
Electrophoresis is an analytical method frequently used in molecular biology and medicine. It is extensively used for the separation and characterization of proteins and nucleic acids for genomics and proteomics research. Electrophoresis techniques have become an integral part of life sciences research due to the growing demand for next-generation sequencing, personalized medicine, and structure-based drug design. Electrophoresis technologies are frequently used in diagnostics, diagnosis of hemoglobinopathies, antibody analysis, drug quality control, vaccine analysis, and DNA sequencing.

The global electrophoresis technologies market is expected to grow at a steady CAGR of 5% to 6% during the forecast period (2015 to 2020). The market is mainly driven by the rising funding for research on electrophoresis techniques, growing number of research collaborations between market players and academic institutions, increasing use of capillary electrophoresis (CE) with mass spectroscopy (MS), and growing focus on next-generation sequencing research.

In this report, the market is segmented by products, applications, end users, and regions. The electrophoresis technologies market is broadly split into three product segments, namely, electrophoresis instrumentation, reagents, and imaging and informatics. The electrophoresis reagents market accounted for the largest share of the electrophoresis technologies product market, in 2014, and is expected to grow at the highest CAGR of 5.4% during the forecast period of 2015 to 2020. A large share of this segment is mainly due to the repetitive use of reagents in various electrophoresis techniques. In addition, the increase in innovations and developments in proteomics and genomic research, availability of funds from various organizations, and increasing R&D expenditure are further propelling the growth of electrophoresis reagents market. The electrophoresis reagents segment is further segmented into protein regents and nucleic acid reagents.

On the other hand, the electrophoresis instrumentation is another major segment of the electrophoresis technologies product market and is segmented into gel electrophoresis systems and capillary electrophoresis systems.

On the basis of applications, the electrophoresis technologies market is segmented into research applications, diagnostic applications, and quality control and process validation. The research applications segment accounted for ~75% share of the electrophoresis technologies market, in 2014. This is mainly due to the extensive use of electrophoresis technologies in life sciences and biotechnology research.

In 2014, North America commanded the largest share to the global electrophoresis technologies market, followed by Europe, Asia-Pacific, and RoW. During the forecast period, developed geographic markets, such as North America and Europe are likely to grow at a lower CAGR as compared to the Asia-Pacific market. Growth in the Asia-Pacific market is largely driven by the increasing investments made by the pharmaceutical and biotechnology companies, rising demand of innovative technologies, and increasing research collaborations and funding in this region.

The global electrophoresis technologies market is consolidated at the top, with top ten players accounting for more than 70% market share in 2014. Some of the major players in the electrophoresis technologies market are Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), QAIGEN N.V. (Netherlands), Sigma-Aldrich Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Harvard BioScience, Inc. (U.S.), and Helena Laboratories (U.S.), GE Healthcare (U.K.), and Shimadzu Corporation (Japan).

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them to garner a greater market share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping greater market shares.

This report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on product portfolios offered by top players in the electrophoresis market. The report analyzes the electrophoresis technologies market by product, application, and end user across all regions
‧ Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the electrophoresis technologies market
‧ Market Development: Comprehensive information on the lucrative emerging markets by product, application, end user, and region
‧ Market Diversification: Exhaustive information about new products, growing regions, recent developments, and investments in the electrophoresis technologies market
‧ Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analysis of leading players in the electrophoresis technologies market
TABLE OF CONTENTS

1 INTRODUCTION 22
1.1 OBJECTIVES OF THE STUDY 22
1.2 MARKET DEFINITION 22
1.3 MARKET SCOPE 23
1.3.1 MARKETS COVERED 23
1.3.2 YEARS CONSIDERED FOR THE STUDY 25
1.4 CURRENCY 25
1.5 LIMITATIONS 25
1.6 STAKEHOLDERS 25
2 RESEARCH METHODOLOGY 26
2.1 RESEARCH APPROACH 26
2.2 MARKET SIZE ESTIMATION 28
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 30
2.4 MARKET SHARE ESTIMATION 31
2.4.1 KEY DATA FROM SECONDARY SOURCES 31
2.4.2 KEY DATA FROM PRIMARY SOURCES 32
2.4.3 KEY INDUSTRY INSIGHTS 33
2.4.4 ASSUMPTIONS FOR THE STUDY 33
3 EXECUTIVE SUMMARY 34
4 PREMIUM INSIGHTS 39
4.1 GROWTH POTENTIAL OF THE ELECTROPHORESIS TECHNOLOGIES MARKET 39
4.2 ASIA-PACIFIC ELECTROPHORESIS TECHNOLOGIES MARKET 40
4.3 ELECTROPHORESIS TECHNOLOGIES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 41
4.4 NORTH AMERICA TO DOMINATE THE GLOBAL ELECTROPHORESIS TECHNOLOGIES MARKET DURING THE FORECAST PERIOD 42
4.5 ELECTROPHORESIS TECHNOLOGIES MARKET: DEVELOPING VS. DEVELOPED COUNTRIES 43
5 MARKET OVERVIEW 44
5.1 INTRODUCTION 45
5.2 MARKET SEGMENTATION 45
5.2.1 BY PRODUCT 45
5.2.2 BY APPLICATION 46
5.2.3 BY END USER 46
?
5.3 MARKET DYNAMICS 47
5.3.1 MARKET DRIVERS 48
5.3.1.1 Increasing government funding for research on electrophoresis techniques 48
5.3.1.2 Growing number of industry-academic research collaborations 49
5.3.1.3 Growing use of Capillary Electrophoresis (CE) with Mass Spectroscopy (MS) 49
5.3.1.4 Growing use of next-generation sequencing 50
5.3.2 MARKET RESTRAINTS 50
5.3.2.1 Presence of alternative technologies offering better efficiency & results 50
5.3.2.2 Time-consuming operations and limited sample analysis 51
5.3.3 MARKET OPPORTUNITIES 51
5.3.3.1 Growing focus on proteomics research in developing countries 51
5.3.3.2 Increasing demand for personalized medicine 52
5.3.4 MARKET CHALLENGES 52
5.3.4.1 Pricing pressure faced by prominent players in emerging markets 52
6 INDUSTRY INSIGHTS 53
6.1 INTRODUCTION 53
6.2 VALUE CHAIN ANALYSIS 53
6.3 INDUSTRY TRENDS 55
6.3.1 TRANSITION FROM MANUAL ELECTROPHORESIS SYSTEMS TO AUTOMATED SYSTEMS 56
6.3.2 PREFERENCE FOR LAB-ON-A-CHIP TECHNOLOGY 56
6.4 PORTER’S FIVE FORCES ANALYSIS 57
6.4.1 THREAT OF NEW ENTRANTS 58
6.4.2 THREAT OF SUBSTITUTES 58
6.4.3 BARGAINING POWER OF SUPPLIERS 59
6.4.4 BARGAINING POWER OF BUYERS 59
6.4.5 INTENSITY OF COMPETITIVE RIVALRY 60
7 GLOBAL ELECTROPHORESIS TECHNOLOGIES MARKET, BY PRODUCT 61
7.1 INTRODUCTION 62
7.2 ELECTROPHORESIS INSTRUMENTATION 63
7.2.1 GEL ELECTROPHORESIS SYSTEMS 65
7.2.1.1 Gel Electrophoresis Systems, by Instruments Type 67
7.2.1.1.1 Horizontal Gel Electrophoresis Systems 67
7.2.1.1.2 Vertical Gel Electrophoresis Systems 68
7.2.1.1.2.1 1D Gel Electrophoresis 69
7.2.1.1.2.2 2D Gel Electrophoresis 70
7.2.1.2 Gel Electrophoresis Systems, by Gel Type 71
7.2.1.2.1 Agarose Gel Electrophoresis 71
7.2.1.2.2 Polyacrylamide gel 72
7.2.2 CAPILLARY ELECTROPHORESIS 73
7.2.2.1 Capillary Zone Electrophoresis 75
7.2.2.2 Capillary Gel Electrophoresis 76
7.2.2.3 Micellar Electrokinetic Capillary Chromatography (MECC) 76
7.2.2.4 Capillary Isotachophoresis 77
7.2.2.5 Capillary Electrochromatography (CEC) 78
7.2.2.6 Capillary Isoelectric Focusing 79
7.3 ELECTROPHORESIS REAGENTS 80
7.3.1 PROTEIN REAGENTS 82
7.3.2 NUCLEIC ACID REAGENTS 83
7.4 ELECTROPHORESIS IMAGING AND INFORMATICS 84
7.4.1 1D ELECTROPHORESIS IMAGING AND INFORMATICS 86
7.4.2 2D ELECTROPHORESIS IMAGING AND INFORMATICS 86
8 GLOBAL ELECTROPHORESIS TECHNOLOGIES MARKET, BY APPLICATION 88
8.1 INTRODUCTION 89
8.2 DIAGNOSTIC APPLICATIONS 90
8.3 RESEARCH APPLICATIONS 92
8.4 QUALITY CONTROL AND PROCESS VALIDATION 93
9 GLOBAL ELECTROPHORESIS TECHNOLOGIES MARKET, BY END USER 95
9.1 INTRODUCTION 96
9.2 ACADEMIC INSTITUTIONS 97
9.3 HOSPITALS & DIAGNOSTIC CENTERS 98
9.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 100
9.5 RESEARCH ORGANIZATIONS 101
10 GLOBAL ELECTROPHORESIS TECHNOLOGIES MARKET, BY GEOGRAPHY 103
10.1 INTRODUCTION 104
10.2 NORTH AMERICA 105
10.2.1 U.S. 110
10.2.2 CANADA 115
10.3 EUROPE 119
10.3.1 GERMANY 125
10.3.2 FRANCE 129
10.3.3 U.K. 133
10.3.4 ITALY 137
10.3.5 SPAIN 141
10.3.6 REST OF EUROPE (ROE) 145
?
10.4 ASIA-PACIFIC 149
10.4.1 JAPAN 155
10.4.2 CHINA 159
10.4.3 INDIA 163
10.4.4 REST OF ASIA-PACIFIC 167
10.5 REST OF THE WORLD (ROW) 171
10.5.1 LATIN AMERICA 176
10.5.2 MIDDLE EAST AND AFRICA 180
11 COMPETITIVE LANDSCAPE 184
11.1 OVERVIEW 184
11.2 MARKET SHARE ANALYSIS 185
11.3 COMPETITIVE SITUATION AND TRENDS 187
11.3.1 EXPANSIONS 187
11.3.2 NEW PRODUCT LAUNCHES 188
11.3.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 189
11.3.4 ACQUISITIONS 190
11.3.5 PRODUCT ENHANCEMENTS 191
12 COMPANY PROFILES 192
12.1 INTRODUCTION 192
12.2 AGILENT TECHNOLOGIES, INC. 193
12.2.1 BUSINESS OVERVIEW 193
12.2.2 PRODUCT PORTFOLIO 194
12.2.3 KEY STRATEGY 194
12.2.4 RECENT DEVELOPMENTS 195
12.3 BIO-RAD LABORATORIES, INC. 196
12.3.1 BUSINESS OVERVIEW 196
12.3.2 PRODUCT PORTFOLIO 197
12.3.3 KEY STRATEGY 199
12.3.4 RECENT DEVELOPMENTS 200
12.4 CBS SCIENTIFIC COMPANY, INC. 201
12.4.1 BUSINESS OVERVIEW 201
12.4.2 PRODUCT PORTFOLIO 201
12.4.3 KEY STRATEGY 201
12.4.4 RECENT DEVELOPMENT 201
12.5 DANAHER CORPORATION 202
12.5.1 BUSINESS OVERVIEW 202
12.5.2 PRODUCT PORTFOLIO 203
12.5.3 KEY STRATEGY 203
12.5.4 RECENT DEVELOPMENT 203
?
12.6 GE HEALTHCARE 204
12.6.1 BUSINESS OVERVIEW 204
12.6.2 PRODUCT PORTFOLIO 205
12.6.3 KEY STRATEGY 205
12.6.4 RECENT DEVELOPMENTS 205
12.7 HARVARD BIOSCIENCE, INC. 206
12.7.1 BUSINESS OVERVIEW 206
12.7.2 PRODUCT PORTFOLIO 207
12.7.3 KEY STRATEGY 207
12.7.4 RECENT DEVELOPMENT 207
12.8 HELENA LABORATORIES 208
12.8.1 BUSINESS OVERVIEW 208
12.8.2 PRODUCT PORTFOLIO 208
12.8.3 KEY STRATEGY 209
12.8.4 RECENT DEVELOPMENTS 209
12.9 PERKINELMER, INC. 210
12.9.1 BUSINESS OVERVIEW 210
12.9.2 PRODUCT PORTFOLIO 211
12.9.3 KEY STRATEGY 211
12.9.4 RECENT DEVELOPMENTS 212
12.10 QIAGEN N.V. 213
12.10.1 BUSINESS OVERVIEW 213
12.10.2 PRODUCT PORTFOLIO 214
12.10.3 KEY STRATEGY 215
12.10.4 RECENT DEVELOPMENTS 215
12.11 SIGMA-ALDRICH CORPORATION 216
12.11.1 BUSINESS OVERVIEW 216
12.11.2 PRODUCT PORTFOLIO 217
12.11.3 KEY STRATEGY 218
12.11.4 RECENT DEVELOPMENTS 219
12.12 SHIMADZU CORPORATION 220
12.12.1 BUSINESS OVERVIEW 220
12.12.2 PRODUCT PORTFOLIO 221
12.12.3 KEY STRATEGY 221
12.12.4 RECENT DEVELOPMENTS 221
12.13 THERMO FISHER SCIENTIFIC, INC. 222
12.13.1 BUSINESS OVERVIEW 222
12.13.2 PRODUCT PORTFOLIO 223
12.13.3 KEY STRATEGY 223
12.13.4 RECENT DEVELOPMENTS 224
?
13 APPENDIX 225
13.1 INSIGHTS OF INDUSTRY EXPERTS 225
13.2 DISCUSSION GUIDE 226
13.3 AVAILABLE CUSTOMIZATIONS 230
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 230
13.5 RELATED REPORTS 232
回上頁